Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptides.
Journal: Frontiers in immunology
Published: June 04, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine.
Journal: NPJ vaccines
Published: April 09, 2025
Vaccine-Induced Antibodies to a C-Terminal Plasmodium falciparum Circumsporozoite Protein Epitope Associated With Protection Against Malaria Challenge.
Journal: The Journal of infectious diseases
Published: March 26, 2025
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
Journal: Annals of internal medicine
Published: February 26, 2024
Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms.
Journal: Nature communications
Published: December 18, 2023
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge.
Journal: The Journal of infectious diseases
Published: August 26, 2023
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
Journal: PLoS neglected tropical diseases
Published: December 04, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Journal: Annals of internal medicine
Published: November 28, 2022
A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection.
Journal: Science translational medicine
Published: August 24, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.
Journal: Infectious diseases and therapy
Published: December 27, 2021
Last Updated: 09/26/2026